ASTELLAS PHARMA INC./ JP3942400007 /
9/1/2024 4:42:35 PM | Chg. 0.000 | Volume | Bid4:42:35 PM | Ask4:42:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
11.135EUR | 0.00% | - Turnover: - |
11.135Bid Size: - | 11.375Ask Size: - | 20.5 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 9.51 JPY | -82.47% |
EPS Diluted: | - JPY | -82.49% |
Revenues per Share: | 881.13 JPY | 4.25% |
Book Value per Share: | 876.91 JPY | 4.49% |
Cash Flow per Share: | 94.77 JPY | -48.05% |
Dividend per Share: | 70.00 JPY | 16.67% |
Total | in mill. | |
Revenues: | 1,603,672.00 JPY | 5.60% |
Net Income: | 17,045.00 JPY | -82.73% |
Operating Cash Flow: | 172,475.00 JPY | - |
Cash and Cash Equivalents: | 335,687.00 JPY | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 191.06 | 172.82 |
P/S Ratio: | 2.06 | 1.87 |
P/BV ratio: | 2.07 | 1.87 |
P/CF Ratio: | 19.17 | 17.34 |
PEG: | -2.32 | -2.10 |
Earnings Yield: | 0.52% | 0.58% |
Dividend Yield: | 3.85% | 4.26% |
Market Capitalization | ||
Market Capitalization: | 20.5 bill. EUR | 19.14 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 1.82 bill. |
Profitability
Gross Profit Margin: | 81.76% |
EBIT Margin: | 1.59% |
Net Profit Margin: | 1.06% |
Return on Equity: | 1.07% |
Return on Assets: | 0.48% |
Financial Strength
Liquidity I / Cash Ratio: | 26.11% |
Liquidity II / Quick Ratio: | 69.28% |
Liquidity III / Current Ratio: | 92.92% |
Debt / Equity Ratio: | 123.66% |
Dynam. Debt / Equity Ratio: | 1,144.29% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - JPY |
Revenues / Employee: | - JPY |
Net Income / Employee: | - JPY |
Total Assets / Employee: | - JPY |
* Fiscal Year End: | 3/31/2024 |
Accounting Standard: | IFRS |
Currency: | JPY |